Biocon’s Pertuzumab breakthrough: first biosimilar to win EMA panel nod under tailored clinical approach
NE HEALTH BUREAU CHENNAI, SEPT 21 Biocon has achieved a significant regulatory milestone in the development of biosimilar therapies for ...
NE HEALTH BUREAU CHENNAI, SEPT 21 Biocon has achieved a significant regulatory milestone in the development of biosimilar therapies for ...
Email:
ne.gowri1964@gmail.com
Phone:
9643255068
Editorial and Administrative Office:
Block No 1 Flat No 4C
Wipro Street, Sholinganallur
Off Old Mabalipuram Road
Chennai 600119, Tamil nadu
96, First Floor, Srinathnagar Society,
(Landmark: Near Panchdev Mandir,
Karmacharinagar Vibhag-I),
Ghatlodia, Ahmedabad-380 061
© 2021 all right reserved by Navjeevanexpress.com. Consulted by MediaHives.com